Open Insider Trading Activity for Denali Therapeutics Inc. Chief Medical Officer Ho Carole
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction DNLI | 2025-08-14 | 2025-08-13 | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 2 | 3,743 | $13.81 | $51,684.30 | 0.86% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting DNLI | 2025-01-08 | 2025-01-07 | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 2 | 15,162 | $20.33 | $308,290.77 | 4.10% | View Filing |
| 10b5-1: Scheduled Form 4 Transaction DNLI | 2024-08-22 | 2024-08-21 | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 3 | 22,458 | $24.49 | $549,927.77 | 5.55% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting DNLI | 2024-08-15 | 2024-08-13 | Denali Therapeutics Inc. | Ho Carole | Chief Medical Officer | Sell | 1 | 2,337 | $22.89 | $53,493.93 | 1.63% | View Filing |